Search filters

List of works by Gerasimos Aravantinos

A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patients

scientific article

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.

scientific article

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study

scientific article

Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.

scientific article

Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

scientific article

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review

scientific article

Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature

scientific article

Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

scientific article

Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection

scientific article published on August 28, 2012

E-Selectin S128R Gene Polymorphism in Gastric Cancer

scientific article published on April 23, 2013

Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk

scientific article published on December 21, 2012

Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy

scientific article

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study

scientific article published on 29 May 2015

Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study

scientific article published on 13 October 2011

Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study

scientific article published in July 2005

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

scientific article

Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study

scientific article published on 25 March 2015

Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression

scientific article published on June 1, 2012

MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

scientific article

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer

scientific article published on 17 May 2016

Oral estramustine and oral etoposide for hormone-refractory prostate cancer

scientific article published on 01 November 1997

Paclitaxel by 3-H infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the hellenic cooperative oncology group

scientific article published on October 1, 1997

Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).

scientific article published in June 2004

Prediction of response to combination chemotherapy with irinotecan in Greek patients with metastatic colorectal cancer

scientific article

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases

scientific article

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study

scientific article published on 04 November 2011

Protein expression patterns of cell cycle regulators in operable breast cancer

scientific article published on 10 August 2017

The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy

scientific article published on June 2017